About
All Posts
Partner
Logo
Login
Subscribe
Logo
  • Home
  • Posts
  • Lilly's donanemab slows Alzheimer's by 35% in early-stage patients

Jul 18, 2023

Lilly's donanemab slows Alzheimer's by 35% in early-stage patients

Bay Area Times
Bay Area Times

Brought to you by:

Hey, welcome to today's Bay Area Times daily newsletter. If you haven't yet already, follow us on Twitter and on Threads!

Top stories today:
1. Alzheimer's: Lilly's drug slows disease by 35% in early-stage patients
2. U.S. plans to restrict some technology investments in China
3. Microsoft granted 2-month trial pause to negotiate Activision deal with UK
4. Threads announces rate limits, citing spam

0. Data and calendar

All values as of 6 AM ET / 3 AM PT, other than S&P500 close (4 PM ET / 1 PM PT).

All times are ET.

1. Lilly's donanemab slows Alzheimer's by 35% in early-stage patients

Lilly's paper on donanemab's Phase 3 clinical trial.

Subscribe to keep reading

This content is free, but you must be subscribed to Bay Area Times to continue reading.

Already a subscriber?Sign in.Not now

Keep reading

Nov 12, 2026

NVIDIA board said to prepare Jensen Huang ouster amid affair revelations, eye CFO as interim CEO

NVIDIA board said to prepare Jensen Huang ouster amid affair revelations, eye CFO as interim CEO

Nov 11, 2026

NVIDIA -5% as firm hires ex-U.S. attorney to probe Jensen Huang’s alleged spy ties

NVIDIA -5% as firm hires ex-U.S. attorney to probe Jensen Huang’s alleged spy ties

Nov 10, 2026

NVIDIA -4% as Trump says FBI probing CEO Jensen Huang’s affair with alleged Chinese spy

NVIDIA -4% as Trump says FBI probing CEO Jensen Huang’s affair with alleged Chinese spy

Nov 9, 2026

NVIDIA board launches spy plot probe as Jensen Huang discloses romantic relationship

NVIDIA board launches spy plot probe as Jensen Huang discloses romantic relationship

Subscribe

Your morning briefing, free forever.

Get the latest news, resources, and more delivered straight to your inbox everyday.

The visual daily newsletter on business and tech. Analyzing the news with 1 visual per story. Join our 250,000+ subscribers here.

Copyright Ā© 2026 Bay Area Times.

BAT

Archive Posts

Partner

Company

About Us

Legal

Privacy Policy

Terms of Service